Breaking News, Collaborations & Alliances

AQEMIA Inks $140M Small Molecule Deal with Sanofi

Collaboration aims to accelerate the discovery of small molecules across various therapeutic areas.

Aqemia, a pharmatech company leveraging AI and quantum-inspired physics to accelerate the discovery of small molecule drug candidates, entered into a multi-year research collaboration with Sanofi to discover small molecule drug candidates across several therapeutic areas. AQEMIA will leverage its unique platform that combines deep physics with generative AI at scale to identify the right chemical molecules for therapeutic targets of interest to Sanofi. The collaboration will span the drug ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters